Ulrike Fuhrmann

This inventor holds 13 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Schering Aktiengesellschaft, Bayer Oy, Bayer Pharma Aktiengesellschaft. Active years: 2001-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ulrike Fuhrmann. Retrieved from https://idiyas.com/inventor/ulrike-fuhrmann

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13 (Patent Applications = 4)

% Patents Active = 23.1

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 3 (Patent Applications = 5)

Average Co-Inventor Count = 7.5

ph-index = 7

Forward Citations = 127(Granted Patents)

Company Filing History:

6 out of 1,409

Schering Aktiengesellschaft

Bayer Pharma Aktiengesellschaft

patents

4. 2 out of 192

Bayer Schering Pharma Ag

patents

5. 1 out of 721

Bayer Intellectual Property Gmbh

patents

Years Active: 2001-2020

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10532025 - Intrauterine delivery system for contraception (2020-01-14),

2. 9999592 - Intrauterine delivery system for contraception (2018-06-19),

3. 9655887 - Pharmaceutical composition and the use thereof, and application regime of said pharmaceutical composition for on-demand contraception (2017-05-23),

4. 9579330 - Use and application regimen of a pharmaceutical composition containing levonorgestrel and a COX inhibitor for on-demand contraception (2017-02-28),

5. 8445469 - 18-methyl-19-nor-17-pregn-4-ene-21,17-carbolactones, as well as pharmaceutical preparations that contain the latter (2013-05-21),

6. 8053426 - Progesterone receptor antagonists (2011-11-08),

7. 7408060 - Nonsteroidal progesterone receptor modulators (2008-08-05),

8. 7388006 - Non-steroidal progesting (2008-06-17),

9. 7378406 - Use of antiprogestins for prophylaxis and treatment of hormone-dependent diseases (2008-05-27),

10. 7148213 - Antigestagenically active steroids with a fluorinated 17α-alkyl chain (2006-12-12),

11. 6806263 - Antigestagenically active steroids with a fluorinated 17-alpha-alkyl chain (2004-10-19),

12. 6503895 - Antigestagenically active steroids with a fluorinated 17&agr;-alkyl chain (2003-01-07),

13. 6316432 - Antigestagenically active steroids with a flourinated 17 &agr;-alkyl chain (2001-11-13),

Title: The Innovative Journey of Ulrike Fuhrmann

Introduction

Ulrike Fuhrmann, a prominent inventor based in Berlin, Germany, has made significant contributions to the field of women's health and contraception. With a remarkable portfolio of 13 patents, her work focuses primarily on intrauterine delivery systems that address various menstrual problems. Fuhrmann's innovations are shaping the way women experience contraception and menstrual health.

Latest Patents

Among her latest patents, Ulrike Fuhrmann has developed an innovative intrauterine delivery system for contraception. This invention involves a method that aims to reduce menstrual problems and induce amenorrhea through a controlled release mechanism. It utilizes a combination of progestogen or a drug with progestogenic activity and at least one therapeutically active substance designed to prevent or suppress abnormal and irregular endometrial bleeding over an extended period. This groundbreaking approach reflects her commitment to improving women's health through effective medical solutions.

Career Highlights

Ulrike Fuhrmann has built a noteworthy career, working with esteemed organizations in the pharmaceutical industry. She has held positions at Schering Aktiengesellschaft and Bayer Schering Pharma AG, where she applied her expertise in developing innovative health solutions. Her dedication and talent as an inventor have led her to thrive in these high-caliber environments.

Collaborations

Throughout her career, Ulrike has collaborated with experts in the field, including notable coworkers such as Wolfgang Schwede and Arwed Cleve. These collaborations have enabled her to combine knowledge and skills with fellow innovators, further enhancing the impact of her inventions.

Conclusion

Ulrike Fuhrmann's contributions to women's health through her innovative inventions in contraception and menstrual management signify her as a leading figure in the field. With numerous patents to her name and a strong career foundation, she continues to inspire future generations of inventors and pave the way for advancements in women's healthcare.

Profile summary based on public USPTO records.